Part B Drugs At Home: Medicare Policy Responds To COVID-Driven Access Concerns

Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.

Intravenous drip
Instead of an intravenous drip, policy change in the coronavirus era has felt more like a bolus.

The US Centers for Medicare and Medicaid Services will allow for Medicare reimbursement of infused or injected Part B drugs administered at home as long as a physician or practitioner is supervising with interactive telecommunications technology, according to an interim final rule released on 30 March.

Entitled “Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency,” the rule also...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet